ANT-GROUP
3.11.2022 04:21:38 CET | Business Wire | Press release
Ant Group today officially launched its Alipay+ D-store™ at the Singapore FinTech Festival 2022. Alipay+ D-store™ is a business digitalization solution designed to support the service industry, especially brick-and-mortar businesses to digitalize their operations to boost efficiency and productivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221102006207/en/
(Photo: Business Wire)
An integrated one-stop solution which businesses can use to build digital stores across multiple digital platforms in a fast, scalable and cost-efficient way, Alipay+ D-store™ provides a suite of toolkits to digitalize merchants' payments, operations, services and marketing, unlocking new revenue opportunities and delivering better services to consumers.
Businesses could have digital stores on digital platforms in the form of mini programmes. Digital stores could also be developed as H5 pages and easily embedded in social media and online to reach consumers. Digital platforms currently partnering with Alipay+ D-store™ include Chope, Alipay, Touch 'n Go eWallet, AlipayHK, etc.
“We welcome more digital platforms to collaborate to accelerate the digitalization of the global service industry together,” Dr. Cherry Huang, Global Head of Alipay+ D-store™ said.
“Leveraging digital solutions is critical for the service industries to boost operational efficiency and adapt to the fast-changing market conditions. The Alipay+ D-store™ solution is developed with the goal to make it easier for brick-and-mortar businesses to go digital at scale, so that businesses can better serve and engage digital-savvy consumers by providing a seamless omni-channel experience,” she added.
Having identified the F&B industry a priority sector, Alipay+ D-store™ solution has been adopted by brands including fast food chain Burger King, Koufu, one of Singapore’s most established and largest operators and managers of food courts and coffee shops, and more than 2,000 local restaurants, cafes and eateries in Singapore, Malaysia, Hong Kong SAR, China and other markets.
At the Festival, Alipay+ D-store™ also unveiled its newest customer, Huggs Coffee, one of Singapore’s largest homegrown cafe chain brands specializing in coffee with over 20 outlets. Huggs will work with Alipay+ D-store™ to digitalize its outlets and operations efficacy, allowing customers to access seamless services through its digital store on Chope and other platforms in future.
Speaking in regard to the partnership, Lee Haoming, Managing Director of Huggs Coffee said: “Huggs is not only a business of F&B, to us, a good cup of coffee is a tool to create social connections. That is why creating a unique and elevated experience beyond the coffee itself is important to Huggs, and we believe digitalization plays an important role in enhancing the experience.”
“We are very excited to partner with Alipay+ D-store™ to transform the Huggs experience! It creates a more efficient operation flow to brew more smiles while reducing time to queue and pay, henceforth allowing our valued customers to spend more quality time on building connections with each other when visiting Huggs.”
To learn more about Alipay+ D-store™ at the Singapore FinTech Festival 2022, visit the Ant Group booth #2E01, or attend the product showcase “It’s A PLUS: How Alipay+ & Partners Build Digital Resilience For Businesses” scheduled at 11:20 a.m., 3 November in Hall 3.
About Ant Group
Ant Group aims to build the infrastructure and platforms to support the digital transformation of the service industry. Through continuous innovation, it strives to provide all consumers and small and micro businesses equal access to digital, financial, and other daily life services that are convenient, sustainable, and inclusive.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221102006207/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom